Adiponectin is a protein hormone that is produced and secreted by adipose tissue, also known as fat cells. It plays an important role in regulating metabolism and insulin sensitivity. Adiponectin is also known as Acrp30, AdipoQ, and GBP28.
Adiponectin levels are inversely correlated with obesity, insulin resistance, type 2 diabetes, and cardiovascular disease. This means that the higher the levels of adiponectin in the body, the lower the risk of developing these conditions.
Adiponectin helps regulate glucose and lipid metabolism by enhancing insulin sensitivity and increasing the oxidation of fatty acids. It also has anti-inflammatory properties, which may contribute to its protective effect against cardiovascular disease.
Low levels of adiponectin have been associated with an increased risk of metabolic disorders, such as insulin resistance, type 2 diabetes, and cardiovascular disease. In contrast, high levels of adiponectin have been associated with improved insulin sensitivity and a lower risk of these conditions.
Measuring adiponectin levels in the blood can provide important information about a person’s risk for developing metabolic disorders. Treatment strategies aimed at increasing adiponectin levels, such as exercise, weight loss, and certain medications, may be beneficial in the prevention and management of these conditions.